Ignite Creation Date:
2025-12-24 @ 3:40 PM
Ignite Modification Date:
2026-02-22 @ 9:36 AM
Study NCT ID:
NCT01767792
Status:
COMPLETED
Last Update Posted:
2021-02-12
First Post:
2013-01-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas
Sponsor:
University of Alabama at Birmingham
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-05-15
Start Date Type:
ACTUAL
Primary Completion Date:
2019-01-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-02-01
Completion Date Type:
ACTUAL
First Submit Date:
2013-01-07
First Submit QC Date:
None
Study First Post Date:
2013-01-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-04-15
Results First Submit QC Date:
None
Results First Post Date:
2020-05-27
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-01-26
Last Update Post Date:
2021-02-12
Last Update Post Date Type:
ACTUAL